
Brian J. Gangle
Examiner (ID: 511, Phone: (571)272-1181 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1233 |
| Issued Applications | 798 |
| Pending Applications | 132 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19767664
[patent_doc_number] => 20250049090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => A NUTRITIONAL SUPPLEMENT FOR IMPROVED GUT HEALTH
[patent_app_type] => utility
[patent_app_number] => 18/719308
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18719308
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/719308 | A NUTRITIONAL SUPPLEMENT FOR IMPROVED GUT HEALTH | Nov 21, 2022 | Pending |
Array
(
[id] => 19674514
[patent_doc_number] => 12186352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology
[patent_app_type] => utility
[patent_app_number] => 17/982067
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 27
[patent_no_of_words] => 13791
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982067
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982067 | Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology | Nov 6, 2022 | Issued |
Array
(
[id] => 19968708
[patent_doc_number] => 12337293
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Chromatography ligand comprising domain c from
[patent_app_type] => utility
[patent_app_number] => 17/981262
[patent_app_country] => US
[patent_app_date] => 2022-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2123
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17981262
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/981262 | Chromatography ligand comprising domain c from | Nov 3, 2022 | Issued |
Array
(
[id] => 18420505
[patent_doc_number] => 20230174967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => DONOR REPAIR TEMPLATES MULTIPLEX GENOME EDITING
[patent_app_type] => utility
[patent_app_number] => 18/048631
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048631
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/048631 | Donor repair templates multiplex genome editing | Oct 20, 2022 | Issued |
Array
(
[id] => 19641380
[patent_doc_number] => 20240415900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => CLOSTRIDIUM BUTYRICUM COMPOSITIONS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/702614
[patent_app_country] => US
[patent_app_date] => 2022-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18702614
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/702614 | CLOSTRIDIUM BUTYRICUM COMPOSITIONS AND METHODS OF USING THE SAME | Oct 19, 2022 | Pending |
Array
(
[id] => 20287191
[patent_doc_number] => 20250312434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-09
[patent_title] => LIPOPOLYSACCHARIDE (LPS) DEFICIENT ACINETOBACTER BAUMANNII MULTIVALENT VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/702767
[patent_app_country] => US
[patent_app_date] => 2022-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18702767
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/702767 | LIPOPOLYSACCHARIDE (LPS) DEFICIENT ACINETOBACTER BAUMANNII MULTIVALENT VACCINE | Oct 19, 2022 | Pending |
Array
(
[id] => 19658514
[patent_doc_number] => 20240425579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => COMPOSITIONS AND METHODS THAT INHIBIT IL-23 SIGNALING
[patent_app_type] => utility
[patent_app_number] => 18/700540
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -127
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700540
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/700540 | COMPOSITIONS AND METHODS THAT INHIBIT IL-23 SIGNALING | Oct 10, 2022 | Pending |
Array
(
[id] => 20729079
[patent_doc_number] => 12636323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-26
[patent_title] => Use of
[patent_app_type] => utility
[patent_app_number] => 18/546553
[patent_app_country] => US
[patent_app_date] => 2022-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 39
[patent_no_of_words] => 1884
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546553
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/546553 | Use of | Oct 8, 2022 | Issued |
Array
(
[id] => 19165862
[patent_doc_number] => 11981750
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Antigenic tripeptides derived from
[patent_app_type] => utility
[patent_app_number] => 17/938865
[patent_app_country] => US
[patent_app_date] => 2022-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 31
[patent_no_of_words] => 18837
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17938865
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/938865 | Antigenic tripeptides derived from | Oct 6, 2022 | Issued |
Array
(
[id] => 18610872
[patent_doc_number] => 20230277602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/937819
[patent_app_country] => US
[patent_app_date] => 2022-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25786
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17937819
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/937819 | COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER | Oct 3, 2022 | Abandoned |
Array
(
[id] => 20180510
[patent_doc_number] => 20250264468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => COMPOSITIONS AND METHODS FOR THE DETECTION OF COCCIDIOIDAL CHITINASE-1
[patent_app_type] => utility
[patent_app_number] => 18/697663
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18697663
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/697663 | COMPOSITIONS AND METHODS FOR THE DETECTION OF COCCIDIOIDAL CHITINASE-1 | Sep 28, 2022 | Pending |
Array
(
[id] => 19991131
[patent_doc_number] => 20250129353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => ENZYME AGENT FOR COLLAGEN TRIPEPTIDE PRODUCTION OR CARTILAGE DEGRADATION
[patent_app_type] => utility
[patent_app_number] => 18/694444
[patent_app_country] => US
[patent_app_date] => 2022-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18694444
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/694444 | ENZYME AGENT FOR COLLAGEN TRIPEPTIDE PRODUCTION OR CARTILAGE DEGRADATION | Sep 26, 2022 | Pending |
Array
(
[id] => 18158302
[patent_doc_number] => 20230024893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => TARS DERIVED FROM AKKERMANSIA MUCINIPHILA OR FRAGMENT THEREOF, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/952990
[patent_app_country] => US
[patent_app_date] => 2022-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17686
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17952990
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/952990 | TARS derived from | Sep 25, 2022 | Issued |
Array
(
[id] => 19682453
[patent_doc_number] => 20250000998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => MEDICAMENT FOR KILLING TUMOR CELLS
[patent_app_type] => utility
[patent_app_number] => 18/694632
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4351
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18694632
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/694632 | MEDICAMENT FOR KILLING TUMOR CELLS | Sep 21, 2022 | Pending |
Array
(
[id] => 19572132
[patent_doc_number] => 20240376424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => EXOPOLYSACCHARIDE PRODUCTION MICROORGANISMS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/682052
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682052
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/682052 | EXOPOLYSACCHARIDE PRODUCTION MICROORGANISMS AND USES THEREOF | Sep 8, 2022 | Pending |
Array
(
[id] => 19089720
[patent_doc_number] => 11951139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Method and system for reducing the likelihood of osteoporosis
[patent_app_type] => utility
[patent_app_number] => 17/893384
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 11454
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17893384
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/893384 | Method and system for reducing the likelihood of osteoporosis | Aug 22, 2022 | Issued |
Array
(
[id] => 19989658
[patent_doc_number] => 20250127880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => FUSION POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 18/685637
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18685637
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/685637 | FUSION POLYPEPTIDE | Aug 22, 2022 | Pending |
Array
(
[id] => 18346604
[patent_doc_number] => 20230134714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/820252
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820252
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820252 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | Aug 16, 2022 | Abandoned |
Array
(
[id] => 18365623
[patent_doc_number] => 20230147214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => METHODS FOR TREATING AND FOR INHIBITING PROGRESSION OF SEIZURES
[patent_app_type] => utility
[patent_app_number] => 17/820029
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820029
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820029 | METHODS FOR TREATING AND FOR INHIBITING PROGRESSION OF SEIZURES | Aug 15, 2022 | Abandoned |
Array
(
[id] => 19209543
[patent_doc_number] => 11998578
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Composition for use in the treatment and/or improvement of sleep and mood disorders
[patent_app_type] => utility
[patent_app_number] => 17/879700
[patent_app_country] => US
[patent_app_date] => 2022-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 31
[patent_no_of_words] => 7219
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17879700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/879700 | Composition for use in the treatment and/or improvement of sleep and mood disorders | Aug 1, 2022 | Issued |